Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Neuro-Signals|October 10, 2009
Muscarinic receptors in psychiatric disorders - can we mimic 'health'?E ScarrCurrent Molecular Medicine|March 31, 2015
Possible involvement of muscarinic receptors in psychiatric disorders: a focus on schizophrenia and mood disordersB Dean, E ScarrCurrent Drug Targets. CNS and Neurological Disorders|June 8, 2004
Antipsychotic drugs: evolving mechanisms of action with improved therapeutic benefitsB Dean, E ScarrCurrent Molecular Medicine|August 29, 2003
Muscarinic receptors in schizophreniaB Dean, F P Bymaster, E ScarrClinical and Experimental Pharmacology & Physiology|January 12, 2001
A proposed pathological model in the hippocampus of subjects with schizophreniaE Scarr, D L Copolov, B DeanTranslational Psychiatry|November 16, 2016
Evidence for impaired glucose metabolism in the striatum, obtained postmortem, from some subjects with schizophreniaB Dean, N Thomas, E Scarr, et al.Molecular Psychiatry|November 2, 2016
Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptorE Scarr, M Udawela, E A Thomas, et al.Bipolar Disorders|August 5, 2003
Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorderE Scarr, G Pavey, S Sundram, et al.Molecular Psychiatry|December 12, 2002
Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophreniaB Dean, M McLeod, D Keriakous, et al.Neuroscience|April 20, 2001
Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis useB Dean, S Sundram, R Bradbury, et al.Pageof 3